top of page
Exponential Logo.png

Before the Eli Lilly Headline, Institutions Had Already Been Buying for a Week

Nov 11
2 min read

Eli Lilly told the market on Monday that its obesity pill Foundayo met the main goal of a late-stage sleep apnea study. The shares gained roughly 4.5% to about $1,415 (CNBC; market data providers).


The flow story, though, started before the headline. Our classified flow — institutional versus retail, buy versus sell, every session — shows institutions had been buying LLY for four straight sessions before the news.


LLY institutional net flow, six sessions, $ millions

What the sessions actually showed


October 30: $957 million of net institutional buying. November 2: $349 million. November 3: $508 million. November 4: $119 million. Four sessions, $1.93 billion of net accumulation, day by day.


Retail did almost none of it. Retail net was under 3% of institutional net on every day of the run — flat, drifting slightly negative.


Then came November 5, the worst tech day since March 2020. Institutions net sold $1.17 billion of LLY, and took another $232 million out on Friday. That is what two-sided data looks like: the same desks that bought for a week cut on the market-wide shock.


Why this matters


Almost nothing in public view shows any of this. Fund flows come monthly or with a 45-day lag. 13F holdings arrive a quarter late. Volume tells you something traded — not who was buying.


The honest public answer to 'who was buying Eli Lilly last week?' has always been: nobody knows.


Our feed answers it daily, by investor group, with buys and sells counted separately — and it delivers at T+1, so Friday 6 November is the newest session shown. Monday's Foundayo reaction isn't in the chart yet.


It will be tomorrow, and it will be the freshest daily record of who moved that stock anywhere in the market.


What we don't know yet


Did Monday's headline bring institutions back, or was Friday's selling the start of an unwind? That is exactly what the daily record settles — tomorrow, one session, one direction, measured.


Want this feed on your own tickers? Write sales@exponential-tech.ai and we'll show you the data on the names you cover.

Comments


Read the research,
then test the data.

Request a white paper from our research library, or book a call with the research team behind it.

bottom of page